Concepedia

Alessandra Di Lelio

AD

Statistics

Publications

4

Citations

68

H-Index

4

Active since

2016

Affiliations

Mayo Clinic Hospital(Current)

Mayo Clinic in Arizona

Tisch Hospital

Mario Negri Institute for Pharmacological Research

Center for Outcomes Research and Clinical Epidemiology

Alessandra Di Lelio is an author at Mayo Clinic Hospital specializing in medicine, clinical pharmacology, and hematologic malignancy therapy.

Publications per year

2016–2020

4

Publications

4

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

John Mascarenhas, Josef T. Prchal, Alessandro Rambaldi et al. · Blood · 2016 · 28 citations

, , +8

Osteopathic Manipulative Treatment in Neonatal Intensive Care Units

Luca Cicchitti, Alessandra Di Lelio, Gina Barlafante et al. · Medical Sciences · 2020 · 15 citations · Full text

, , +15

Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)

Raajit K. Rampal, John Mascarenhas, Heidi Kosiorek et al. · Blood · 2016 · 14 citations

, , +12

Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety

Paola Ponzani, Cesare Berra, Alessandra Di Lelio et al. · Diabetes Therapy · 2018 · 11 citations · Full text

, , +17

1–4 of 4